Open post

2nd General Assembly Meeting

TransQST GAM2 took place in Paris (France) in October 2018

The 2nd General Assembly Meeting took place on the 17th and 18th of October 2018, at the Chilly Mazarin centre of Sanofi pharma in Paris (France). This 2-day meeting was organized following the same structure of GAM1 held in April 2018, as follows: Day 1 – parallel workshop style meetings of Organ related WPs with […]

Read moreMore Tag
Open post

TransQST poster at the EUROTOX conference

TransQST poster at the EUROTOX in Brussels (Belgium) in September 2018

A poster of the TransQST work contributed by the University of Maastricht partner to the project was presented at the EUROTOX, 2-5th September in Brussels. In addition to the poster session participation, UM colleagues were also invited to present this poster in the Astrazeneca Educational Event, organized in the framework of the conference on the […]

Read moreMore Tag
Open post

The TXG-rMAP, an innovative WGCNA tool

UL partner presents their WGCNA tool

The Research Division of Drug Discovery and Safety of the University of Leiden (UL) participates to TransQST consortium. Bob van de Water lab team has mined the data of TG-GATEs database on primary human hepatocytes gene expression data and established WGCNA modules. These modules are available in an open source application  tool called TXG-rMAP. Co-regulated […]

Read moreMore Tag
Open post

TransQST at the IMI 10th anniversary

TransQST posters at the IMI 10th anniversary scientific symposium in October 2018

TransQST got acceptation of two abstracts submitted for the IMI 10th anniversary scientific symposium that will take place in Brussels on the 22nd and 23rd of October of 2018. ULIV and FIMIM partners will present their work within TransQST project in two posters presentations entitled as follows: IMIM – Network-based modeling of APAP-induced hepatotoxicity using […]

Read moreMore Tag

Posts navigation

1 2 3 4